Reported Consolidated quarterly numbers for Brooks Laboratories are:Net Sales at Rs 28.46 crore in March 2022 up 94.74% from Rs. 14.62 crore in March 2021.
Quarterly Net Loss at Rs. 3.60 crore in March 2022 up 79.17% from Rs. 17.30 crore in March 2021.
EBITDA stands negative at Rs. 3.73 crore in March 2022 up 3.37% from Rs. 3.86 crore in March 2021.
Brooks Labs shares closed at 83.70 on May 30, 2022 (NSE) and has given -20.36% returns over the last 6 months and -15.11% over the last 12 months.
| Brooks Laboratories | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'22 | Dec'21 | Mar'21 | | Net Sales/Income from operations | 28.46 | 19.01 | 14.62 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 28.46 | 19.01 | 14.62 | | EXPENDITURE | | Consumption of Raw Materials | 22.51 | 15.45 | 6.77 | | Purchase of Traded Goods | 0.66 | 0.11 | 0.22 | | Increase/Decrease in Stocks | -4.42 | -0.80 | 1.82 | | Power & Fuel | -- | -- | -- | | Employees Cost | 5.45 | 4.99 | 3.99 | | Depreciation | 1.95 | 1.88 | 1.74 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 8.17 | 5.63 | 5.75 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -5.86 | -8.26 | -5.66 | | Other Income | 0.18 | 0.37 | 0.06 | | P/L Before Int., Excpt. Items & Tax | -5.68 | -7.90 | -5.60 | | Interest | 0.84 | 0.74 | 0.74 | | P/L Before Exceptional Items & Tax | -6.52 | -8.64 | -6.35 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.52 | -8.64 | -6.35 | | Tax | -0.58 | -1.23 | 10.38 | | P/L After Tax from Ordinary Activities | -5.94 | -7.40 | -16.73 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.94 | -7.40 | -16.73 | | Minority Interest | 2.33 | -- | -- | | Share Of P/L Of Associates | -- | -- | -0.57 | | Net P/L After M.I & Associates | -3.60 | -7.40 | -17.30 | | Equity Share Capital | 24.70 | 24.70 | 24.70 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.46 | -3.14 | -6.93 | | Diluted EPS | -1.46 | -3.16 | -6.93 | | EPS After Extra Ordinary | | Basic EPS | -1.46 | -3.14 | -6.93 | | Diluted EPS | -1.46 | -3.16 | -6.93 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
